摘要:
Substituted cyclohexanols and cyclohexylamines and derivatives thereof of the formula I as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
摘要:
Verbindungen der Formel (I) und deren Stereoisomere worin A,B,C',D = unabhängig voneinander CH oder N, wobei mindestens eines der Symbole A,B,C',D einem Stickstoffatom entsprechen muß, X = CH 2 oder Sauerstoff, R 1 = ein an ein C-Atom gebundener Rest, der H, Trialkylsilyl, Halogen, Nitro, Cyano, Alkenyl, Alkinyl, Amino, Cycloalkyl, Phenyl, Phenoxy, Alkoxy, Alkenyloxy, Alkinyloxy, Hydroxycarbonyl, Alkylthio, Cycloalkyloxy, Alkylcarbonyl, Alkoxycarbonyl, Alkenyloxycarbonyl, Alkinyloxycarbonyl, Halogenalkyl, Alkoxyalkyl, Halogenalkoxy, Halogenalkylthio, Halogenalkoxyalkyl, Alkylthioalkyl, Alkoxyalkoxy, Halogenalkoxyalkoxy, Alkenyloxyalkoxy, Halogenalkenyloxy, Alkoxyalkylthio, Alkylthioalkoxy, Alkylthioalkylthio, Halogenalkoxycarbonyl, Halogenalkenyloxycarbonyl oder Dialkylamino oder zwei R 1 , wenn sie ortho ständig zueinander orientiert sind, zusammen einen Methylendioxy-, Ethylendioxy-oder Alkylenrest; R 2 ,R 3 unabhängig voneinander Alkyl, Alkenyl, Phenyl oder R 2 oder R 3 eine Alkylenkette, die - zusammen mit dem quartären Kohlenstoffatom einen unsubstituierten oder fluor-substituierten Ring mit drei bis sechs Ringgliedern ergibt, R 5 = Pyridyl, Furyl, Thienyl, die alle substituiert sein können, Phthalimidyl, Dialkylmaleinimidyl, Thiophthalimidyl, Dihydrophthalimidyl, Tetrahydrophthalimidyl, substituiertes Phenyl oder R 4 und R 5 -zusammen mit dem sie verbrückenden Kohlenstoffatom - einen gegebenenfalls substituierten Indanyl-, Cyclopentenoyl-oder Cyclopentenyl-Rest und n = 0, 1 oder 2 bedeuten, besitzen vorteilhafte Eigenschaften bei der Bekämpfung von Schädlingen, insbesondere von Insekten und Akariden. Ferner werden Verfahren zur Herstellung von Verbindungen der Formel I beschrieben.
摘要:
The present invention provides a novel indole derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof. The compound according to the present invention can selectively inhibit histone deacetylase (HDAC), and thus can be used to effectively treat a disease associated with histone deacetylase (HDAC) activity.
摘要:
This invention relates to compounds (Formula (1)) that are agonists of the muscarinic M1 receptor and which are useful in the treatment of muscarinic M1 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula where R1-R5, X1, X2 and p are as defined herein.
摘要:
Compounds of the formula I in which R1-R3 have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
摘要:
The present invention is directed to a new class of hydroxamic acid derivatives of formula I, wherein the variables G, T, D, L, R1, R2, R3 are as described herein, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections in a patient in need thereof.